501
Views
4
CrossRef citations to date
0
Altmetric
Original Research Articles

Human papillomavirus and oropharyngeal cancer in Greenland in 1994–2010

, , , , , , & show all
Article: 22386 | Received 19 Jul 2013, Accepted 04 Sep 2013, Published online: 06 Nov 2013

References

  • Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009; 45: 309–16.
  • Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, etal. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet. 2003; 362: 933–40.
  • Stambuk HE, Karimi S, Lee N, Patel SG. Oral cavity and oropharynx tumors. Radiol Clin North Am. 2007; 45: 1–20.
  • Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, etal. NORDCAN – a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010; 49: 725–36.
  • Lajer CB, Buchwald C. The role of human papillomavirus in head and neck cancer. APMIS. 2010; 118: 510–19.
  • Jensen RG, Friborg J, Rosborg J, Specht L, Brofeldt S, Hamilton TM, etal. Survival of head and neck cancer in Greenland. Int J Circumpolar Health. 2010; 69(4): 373–82.
  • Bjerregaard P, Mulvad G, Pedersen HS. Cardiovascular risk factors in Inuit of Greenland. Int J Epidemiol. 1997; 26(6): 1182–90.
  • Kelly J, Lanier A, Santos M, Healey S, Louchini R, Friborg J, etal. Cancer among the circumpolar Inuit, 1989–2003. II. Patterns and trends. Int J Circumpolar Health. 2008; 67: 408–20.
  • Yu GP, Mehta V, Branovan D, Huang Q, Hashibe M, Zhang ZF, etal. Improved survival among patients with base of tongue and tonsil cancer in the United States. Cancer Causes Control. 2012; 23: 153–64.
  • Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, Garnaes E, etal. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer. 2011; 104: 830–40.
  • Heng B, Glenn WK, Ye Y, Tran B, Delprado W, Lutze-Mann L, etal. Human papilloma virus is associated with breast cancer. Br J Cancer. 2009; 101: 1345–50.
  • Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males – Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011; 60: 1705–8.
  • Werdelin L, Misfeldt J, Melbye M, Olsen J. An update on knowledge and sexual behaviour among students in Greenland. Monitoring of the stop-AIDS campaign. Scand J Soc Med. 1992; 20: 158–64.
  • Kjaer SK, Nielsen NH. Cancer of the female genital tract in Circumpolar Inuit. Acta Oncol. 1996; 35: 581–7.
  • Hemminki K, Dong C, Frisch M. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev. 2000; 9(6): 433–7.
  • Pim D, Banks L. Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses. APMIS. 2010; 118: 471–93.
  • Wise-Draper TM, Wells SI. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci. 2008; 13: 1003–17.
  • Microgen Bioproducts. HPV Genotyping by INNO LiPA. 2012. [cited 2013 Jul 6]. Available from: http://www.microgenbioproducts.com/pdf/Microlab%20Newsletters/MLAB_019.pdf.
  • Munoz N, Bosch FX, de SS, Herrero R, Castellsague X, Shah KV, etal. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348: 518–27.
  • Sebbelov AM, Davidson M, Kruger KS, Jensen H, Gregoire L, Hawkins I, etal. Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes Infect. 2000; 2: 121–6.
  • Statens Serum Institut. Childrens vaccination program in Denmark and Greenland. 2013. [cited 2013 Oct 24]. Available from: http://www.ssi.dk/English/HealthdataandICT.
  • DAHANCA (Danish Head And Neck Group). Database registering head and neck cancer in Denmark. [cited 2013 Oct 7]. Available from: http://www.dahanca.dk.
  • Qiagen. Protocol: isolation of genomic DNA from FFPE tissue sections. The QIAamp DNA FFPE tissue handbook. 2007; 12–14. Copenhagen: Qiagen Nordic.
  • Desjardins P, Hansen JB, Allen M. Microvolume protein concentration determination using the NanoDrop 2000c spectrophotometer. J Vis Exp. 2009. pii: 1610. doi: 10.3791/1610.
  • Barber RD, Harmer DW, Coleman RA, Clark BJ. GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics. 2005; 21: 389–95.
  • Weinberger PM, Yu Z, Kountourakis P, Sasaki C, Haffty BG, Kowalski D, etal. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis. Otolaryngol Head Neck Surg. 2009; 141: 382–9.
  • Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, etal. Molecular classification identifies a subset of human papillomavirus – associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006; 24: 736–47.
  • Statistics Greenland. 2012. Population data on Greenland. [cited 2013 Jul 6]. Available from: http://www.stat.gl/default.asp?lang=en.
  • Dean AG, Sullivan KM, Soe MM. OpenEpi: open source epidemiologic statistics for public health, Version 2.3.1. 2013. [cited 2013 May 7]. Available from: www.OpenEpi.com.
  • Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, etal. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res. 2011; 17: 6262–71.
  • Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, etal. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta-analysis of trends by time and region. Head Neck. 2013; 35: 745–55.
  • Mizumachi T, Kano S, Sakashita T, Hatakeyama H, Suzuki S, Homma A, etal. Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma. Int J Clin Oncol. 2012
  • Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan'gina O, etal. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol. 2010; 39: 166–81.
  • Svare EI, Kjaer SK, Worm AM, Osterlind A, Moi H, Christensen RB, etal. Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence. Int J Cancer. 1998; 75: 1–8.
  • Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis. 2010; 37: 386–91.
  • Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, etal. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA. 2012; 307: 693–703.
  • Castillo JP, Kowalik TF. Human cytomegalovirus immediate early proteins and cell growth control. Gene. 2002; 290: 19–34.
  • Helt AM, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis. 2003; 24: 159–69.
  • Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol. 2005; 37: 961–76.
  • Burd CE, Sorrentino JA, Clark KS, Darr DB, Krishnamurthy J, Deal AM, etal. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell. 2013; 152: 340–51.
  • Canepa ET, Scassa ME, Ceruti JM, Marazita MC, Carcagno AL, Sirkin PF, etal. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life. 2007; 59: 419–26.
  • Greer CE, Wheeler CM, Manos MM. Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods Appl. 1994; 3: S113–22.
  • Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, etal. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008; 100: 407–20.
  • Olaleye O, Moorthy R, Lyne O, Black M, Mitchell D, Wiseberg J. A 20-year retrospective study of tonsil cancer incidence and survival trends in South East England: 1987–2006. Clin Otolaryngol. 2011; 36: 325–35.
  • Schwarz TF, Huang LM, Medina DM, Valencia A, Lin TY, Behre U, etal. Four-year follow-up of the immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine when administered to adolescent girls aged 10–14 years. J Adolesc Health. 2012; 50: 187–94.
  • Baandrup L, Blomberg M, Dehlendorff C, Sand C, Andersen KK, Kjaer SK. Significant decrease in the incidence of genital warts in young danish women after implementation of a national human papillomavirus vaccination program. Sex Transm Dis. 2013; 40: 130–5.
  • Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, etal. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29: 4294–301.